A Randomized Comparison of Different Vaginal Self-sampling Devices and Urine for Human Papillomavirus Testing-Predictors 5.1
You are here
12/07/2021
Cadman et al, Cancer Epidemiol Biomarkers Prev. 2021
Aim: To compare high-risk HPV positivity rates, sensitivity and acceptability of five self-sampling methods in the same women taken at the same time.
Partners: Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College, London, United Kingdom; Colposcopy Department, Royal London Hospital, London, United Kingdom